|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| C07D 417/14 | |||
| C07D 471/04 | |||
| C07D 473/34 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Number of the document | 2729459 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12729352.0 |
| Date of filing the European patent application | 2012-06-11 | |
| (97) | Date of publication of the European application | 2014-05-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/002469 |
| Date | 2012-06-11 |
| (87) | Number | WO 2013/004332 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201161505376 P | 2011-07-07 | US |
| (72) |
HEINRICH, Timo, DE
BRUGGER, Nadia, US
JOSEPHSON, Kristopher, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | SUBSTITUTED AZAHETEROCYCLES FOR THE TREATMENT OF CANCER |
| SUBSTITUTED AZAHETEROCYCLES FOR THE TREATMENT OF CANCER |